Replies to post #118127 on Amarantus Bioscience Holdings Inc (AMBS)

[SidVicious]

You mean hope can be brought to market. Gerald said himself, assuming you heard his lackluster presentation imo, that this is now an issue of EXECUTION in bringing ESS to market. So far, everything this company has executed has blown up in its face. the three stooges could do a better job executing. What is very promising, and if I understood correctly, is if ESS can get the special designation from the FDA for expedited review and then sell the voucher for big money. Retrophin, the company founded by that unscrupulous Shkreli, sold their voucher to Sanofi for $245 million.

[JPetroInc]

would like to see the $17-MIL. USDOD grant come down next - would suspect today's 2nd PR regarding ESS was an intentional 'advertisement' to the Fed that AMBS is committed to ESS

Now where's that $150-Mil. IUO Gold Standard market LymPro was supposed to be tapping long ago?